Harpoon Therapeutics' Series B Round

Harpoon Therapeutics raised a round of funding on May 25, 2017.

Harpoon Therapeutics is an immuno-oncology company focused on the discovery and development of novel T-cell engaging biologics for the treatment of cancer and other diseases. Harpoon Therapeutics crea…

Articles about Harpoon Therapeutics' Series B Round: